Long-term results and analyses of correlations 5 years after varicose vein stripping;Langzeitergebnisse und analysen von zusammenhängen 5 jahre nach varizenstripping

Phlebologie

Volumn 39, Issue 5, 2010, Pages 263-269

  Faubel, Roman ^a   Schafer I ^a   Augustin, M ^a   Bruning, G ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Tabea GmbH and Co KG   (Germany)

Author keywords

Obesity; Recurrence classification; Recurrence rate; Symptoms; Varicose vein surgery

Indexed keywords

ARTICLE; BODY MASS; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; RECURRENT DISEASE; REOPERATION; SAPHENOUS VEIN; VARICOSIS; VEIN INSUFFICIENCY; VEIN STRIPPING;

EID: 78149374046     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1622322     Document Type: Article

References (33)

1. Allegra C, Antignani PL, Carlizza A. Recurrent varicose veins following surgical treatment: our experience with five years follow-up. Eur J Vasc Endovasc Surg 2007 Juni; 33(6): 751-756.
2. Bhatti TS, Whitman B, Harradine K et al. Cause of re-recurrence after polytetrafluoroethylene patch saphenoplasty for recurrent varicose veins. Br J Surg 2000; 87: 1356-1360.
3. Couvelard A, O'Toole D, Leek R et al. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Histopathology 2005; 46: 668-676.
4. Creton D. Hypothèses étiologiques des récidives variqueuses saphène interne: étude anatomique sur 211 cas. In: Negus D, Jantet G, Colleridge-Smith PD, eds. Phlebology. London: Springer 1995; 164-168.
5. Creton D. 125 reinterventions for recurrent popliteal varicose veins after excision of the short saphenous vein. Anatomical and physiological hypotheses of the mechanism of recurrence. J Mal Vasc 1999; 24: 30-37.
6. Dachs GU, Tozer GM. Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploition. Eur J Cancer 2000; 36: 1649-1660.
7. De Maeseneer MG, Giuliani DR, Schil VPE, De Hert SG. Can interposition of a silicone implant after sapheno-femoral ligation prevent recurrent varicose veins? Eur J Vasc Endovasc Surg 2002; 24: 245-249.
8. De Maeseneer MG, Philipsen TE, Vandenbroeck CP et al. Closure of the cribriform fascia: an efficient anatomical barrier against postoperative neovascularisation at the saphenofemoral junction? A prospective study. Eur J Vasc Endovasc Surg 2007; 34(3): 361-366.
9. De Maeseneer MG, Tielliu IF, Van Schil PE, De Hert SG, Eyskens EJ. Clinical relevance of neovascularisation on duplex-ultrasound in the longterm follow-up after varicose vein operation. Phlebology 1999; 14: 118-122.
10. Dwerryhouse S, Davies B, Harradine K, Earnshaw JJ. Stripping the long saphenous vein reduces the rate of reoperation for recurrent varicose veins: Five-year results of a randomized trial. J Vasc Surg 1999; 29: 589-592. (Pubitemid 29181229)
11. Earnshaw JJ, Davies B, Harradine K, Heather BP. Preliminary results of PTFE Patch saphenoplasty to prevent neovascularisation leading to recurrent varicose veins. Phlebology 1998; 13: 10-13.
12. Fischer R, Chandler JG, De Maeseneer MG et al. The unresolved problem of recurrent saphenofemoral reflux. J Am Coll Surg 2002; 195: 80-94.
13. Fischer R, Kluess HG, Frings N et al. Der aktuelle Stand der Magnakrossenrezidiv-Forschung. Phlebologie 2003; 32: 54-59.
14. Fischer R, Linde N, Duff C, Jeanneret C, Seeber P. Das Krosserezidiv - eine Nachkontrolle nach 34 Jahren. Phlebologie 2000; 29: 17-22.
15. Frings N, Tran VTP, Nelle A, Glowacki P. Crossenrezidiv der Vena saphena magna trotz korrekter Crossektomie: Neoangiogenese. Phlebologie 1999; 28: 144-148.
16. Gibbs PJ, Foy DMA, Darke SG. Reoperation for recurrent saphenofemoral incompetence: a prospective randomized trial using a reflected flap of pectineus fascia. Eur J Vasc Endovasc Surg 1999; 18: 494-498.
17. Haas E, Burkhardt T, Maile N. Rezidivhäufigkeit durch Neoangiogenese nach modifizierter Krossektomie. Phlebologie 2005; 34: 101-104.
18. Hartmann K, Klode J, Pfister R et al. Recurrent varicose veins: sonography-based re-examination of 210 patients 14 years after ligation and saphenous vein stripping. Vasa 2006 Feb; 35(1): 21-26.
19. Heim D, Negri M, Schlegel U, De Maeseneer M. Resecting the great saphenous stump with endothelial inversion decreases neither neovascularisation nor thigh varicosity recurrence. J Vasc Surg 2008; 47(5): 1028-1032.
20. Hoeben A, Landuyt B, Highley MS et al. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56: 549-580. (Pubitemid 39658463)
21. 2. Phlebologie 2005; 34: 251-254.
22. Hollingsworth SJ, Powell G, Barker SG et al. Primary varicose veins: altered transcription of VEGF and its receptors (KDR, flt-1, soluble flt-1) with sapheno-femoral junction incompetence. Eur J Vasc Endovasc Surg 2004; 27: 259-268.
23. Jeanneret C, Fischer R, Galeazzi RL et al. Langzeitergebnisse nach Crossektomie, Stripping der Vena Saphena magna und endoskopischer Durchtrennung insuffizienter Perforansvenen, erhoben durch eine Fragebogenauswertung (Abstract). VASA 1999; 28: 231.
24. Jones L, Braithwaire BD, Selwyn D et al. Neovascularization is the principle cause of varicose vein recurrence: results of a randomised trial of stripping the long saphenous vein. Eur J Vasc Endovasc Surg 1996; 12: 442-445.
25. Kluess HG, Gallenkemper G, Mulkens PJM, Rabe E. Die modifizierte Crossektomie der Vena saphena magna - farbduplexsonographische Kontrolle nach 2,5 Jahren. Abstract. Vasomed 1997; 4 (Suppl): 9.
26. Kroeger K, Ose C, Rudofsky G et al. CEAP-classes and symptoms in people with varicose veins. Phlebologie 2005; 34: 305-309. (Pubitemid 43066811)
27. Merchant RF, Pichot O. Long-term outcomes of endovenous radiofrequency obliteration of saphenous reflux as a treatment for superficial venous insufficiency. J Vasc Surg 2005; 42(3): 502-509; discussion 509.
28. Merchant RF, Pichot O, Myers KA. Four-year follow-up on endovascular radiofrequency obliteration of great saphenous reflux. Dermatol Surg 2005; 31(2): 129-134.
29. Rewerk S, Noppeney T, Winkler M et al. Pathogenese der Primär- und Rezidivvarikosis an der Magna-Crosse. Die Rolle von VEGF und VEGF-Rezeptor. Phlebologie 2007; 36: 137-142.
30. San Nicolo M, Schullian W. Die Rezidivvarikosis in der Kniekehle. Gefäßchirurgie 1998; 3: 34-36.
31. Sheppard M. A procedure for the prevention of recurrent saphenofemoral incompetence. Aust N Z J Surg 1978; 48: 322-326.
32. Tsuzuki Y, Fukumura D, Oosthuyse B et al. Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha hypoxia response element VEGF cascade differently regulates vascular response and growth rate in tumors. Cancer Res 2000; 60: 6248-6252.
33. Winterborn RJ, Earnshaw JJ. Randomized trial of polytetrafluoroethylene patch insertion for recurrent great saphenous varicose veins. Eur J Vasc Endovasc Surg 2007; 34(3): 367-373. (Pubitemid 47194419)